Harbin Pharmaceutical Group Co Ltd - Asset Resilience Ratio

Latest as of September 2012: 0.97%

Harbin Pharmaceutical Group Co Ltd (600664) has an Asset Resilience Ratio of 0.97% as of September 2012. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.

Liquid Assets

CN¥150.00 Million
≈ $21.95 Million USD Cash + Short-term Investments

Total Assets

CN¥15.40 Billion
≈ $2.25 Billion USD All company assets

Resilience Assessment

Low
Financial Resilience Level

Asset Resilience Ratio Trend (1993–2006)

This chart shows how Harbin Pharmaceutical Group Co Ltd's Asset Resilience Ratio has changed over time. Check how strategically is Harbin Pharmaceutical Group Co Ltd's equity deployed to assess the company's strategic physical and investment asset allocation.

Liquid Assets Composition Over Time

This chart breaks down Harbin Pharmaceutical Group Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see market cap of Harbin Pharmaceutical Group Co Ltd.

Current Liquid Assets Breakdown

Component Amount % of Total Assets
Cash & Equivalents CN¥0.00 0%
Short-term Investments CN¥150.00 Million 0.97%
Total Liquid Assets CN¥150.00 Million 0.97%

Asset Resilience Insights

  • Limited Liquidity: Harbin Pharmaceutical Group Co Ltd maintains only 0.97% of assets in liquid form.
  • This low level may indicate efficient asset utilization but could pose risks during economic downturns.
  • The company has significant short-term investments, indicating active treasury management.

Harbin Pharmaceutical Group Co Ltd Industry Peers by Asset Resilience Ratio

Compare Harbin Pharmaceutical Group Co Ltd's asset resilience ratio with other companies in the same industry.

Company Industry Asset Resilience Ratio
Takeda Pharmaceutical Company Limited
F:TKDA
Drug Manufacturers - Specialty & Generic 0.69%
Sandoz Group AG
SW:SDZ
Drug Manufacturers - Specialty & Generic 7.89%
Viatris Inc
NASDAQ:VTRS
Drug Manufacturers - Specialty & Generic 1.62%
China Resources Sanjiu Medical & Pharmaceutical Co Ltd
SHE:000999
Drug Manufacturers - Specialty & Generic 5.22%
Humanwell Healthcare Group Co Ltd
SHG:600079
Drug Manufacturers - Specialty & Generic 2.75%
Chengdu Kanghong Pharmaceuticals Group Co Ltd
SHE:002773
Drug Manufacturers - Specialty & Generic 4.31%
Regencell Bioscience Holdings Ltd
NASDAQ:RGC
Drug Manufacturers - Specialty & Generic 43.05%
Avadel Pharmaceuticals PLC
NASDAQ:AVDL
Drug Manufacturers - Specialty & Generic 5.90%

Annual Asset Resilience Ratio for Harbin Pharmaceutical Group Co Ltd (1993–2006)

The table below shows the annual Asset Resilience Ratio data for Harbin Pharmaceutical Group Co Ltd.

Year Asset Resilience Ratio (%) Liquid Assets Total Assets Change
2006-12-31 0.02% CN¥2.00 Million
≈ $292.85K
CN¥9.40 Billion
≈ $1.37 Billion
+0.02pp
2003-12-31 0.00% CN¥52.00K
≈ $7.61K
CN¥6.58 Billion
≈ $962.60 Million
0.00pp
2002-12-31 0.00% CN¥59.00K
≈ $8.63K
CN¥5.95 Billion
≈ $871.18 Million
0.00pp
2001-12-31 0.00% CN¥224.00K
≈ $32.78K
CN¥5.77 Billion
≈ $843.79 Million
-0.01pp
2000-12-31 0.01% CN¥436.00K
≈ $63.80K
CN¥4.45 Billion
≈ $651.09 Million
-0.01pp
1997-12-31 0.02% CN¥462.10K
≈ $67.62K
CN¥2.90 Billion
≈ $424.54 Million
-0.01pp
1996-12-31 0.02% CN¥582.32K
≈ $85.21K
CN¥2.49 Billion
≈ $364.10 Million
-0.05pp
1995-12-31 0.07% CN¥1.79 Million
≈ $262.10K
CN¥2.40 Billion
≈ $350.93 Million
-0.16pp
1994-12-31 0.24% CN¥5.60 Million
≈ $819.31K
CN¥2.35 Billion
≈ $343.55 Million
-0.04pp
1993-12-31 0.28% CN¥6.30 Million
≈ $922.28K
CN¥2.24 Billion
≈ $327.42 Million
--
pp = percentage points

About Harbin Pharmaceutical Group Co Ltd

SHG:600664 China Drug Manufacturers - Specialty & Generic
Market Cap
$1.17 Billion
CN¥8.01 Billion CNY
Market Cap Rank
#8339 Global
#2006 in China
Share Price
CN¥3.18
Change (1 day)
+1.27%
52-Week Range
CN¥2.93 - CN¥4.44
All Time High
CN¥8.34
About

Harbin Pharmaceutical Group Co., Ltd., together with its subsidiaries, engages in the research, development, manufacture, wholesale, and retail of pharmaceuticals in China and internationally. The company offers pharmaceutical products for respiratory, chronic, digestive, blood and hematopoietic, anti-tumor and immunomodulatory, anti-inflammatory and analgesic, anti-virus and anti-infection, cere… Read more